Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Clinical and Molecular Hepatology
|
March 19, 2025
Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?
Mathias Jachs, Mattias Mandorfer
Clinics in Liver Disease
|
April 11, 2021
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach
Mathias Jachs, Thomas Reiberger
Clinical and Molecular Hepatology
|
April 16, 2025
Reply to authors' reply: "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"
Mathias Jachs, Mattias Mandorfer
Hepatology (Baltimore, Md.)
|
September 17, 2022
It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B
Mathias Jachs, Hans L Tillmann
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 6, 2021
Reply
Mattias Mandorfer, Thomas Reiberger, Mathias Jachs
Alimentary Pharmacology & Therapeutics
|
January 15, 2023
Letter: chronic HDV infection-is ignorance bliss? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Alimentary Pharmacology & Therapeutics
|
May 26, 2026
Editorial: Bile Acids Under Bulevirtide-A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply
Marlene Hintersteininger, Thomas Reiberger, Mathias Jachs
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Clinical and Molecular Hepatology
|
November 23, 2022
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Clinical and Molecular Hepatology
|
March 19, 2025
Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?
Mathias Jachs, Mattias Mandorfer
Clinics in Liver Disease
|
April 11, 2021
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach
Mathias Jachs, Thomas Reiberger
Clinical and Molecular Hepatology
|
April 16, 2025
Reply to authors' reply: "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"
Mathias Jachs, Mattias Mandorfer
Hepatology (Baltimore, Md.)
|
September 17, 2022
It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B
Mathias Jachs, Hans L Tillmann
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 6, 2021
Reply
Mattias Mandorfer, Thomas Reiberger, Mathias Jachs
Alimentary Pharmacology & Therapeutics
|
January 15, 2023
Letter: chronic HDV infection-is ignorance bliss? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Alimentary Pharmacology & Therapeutics
|
May 26, 2026
Editorial: Bile Acids Under Bulevirtide-A Pharmacodynamic Signature, Not a Prognostic Biomarker. Authors' Reply
Marlene Hintersteininger, Thomas Reiberger, Mathias Jachs
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Clinical and Molecular Hepatology
|
November 23, 2022
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Page
of 12